Reference
Tlemsani C, et al. BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic Medicine. American Journal of the Medical Sciences 356: 404-407, No. 4, Oct 2018. Available from: URL: http://doi.org/10.1016/j.amjms.2018.04.015 - France
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1732, 46 (2018). https://doi.org/10.1007/s40278-018-55502-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-55502-0